Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate
Clinical trial NCT01373151 · COMPLETED
Trial details
- NCT number
- NCT01373151
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-09-01
- Enrollment
- 418
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.